Abstract
A series of chalconyl-incorporated hydrazone derivatives of mefenamic acid was synthesized in order to obtain new compounds with potential analgesic and anti-inflammatory activity having lesser side effects. The structures of all synthesized compounds were confirmed by means of elemental analysis, IR, 1H NMR, 13C NMR and mass spectra. All compounds were evaluated for their analgesic and anti-inflammatory activities by tail-flick method and carrageenan-induced rat paw edema test, respectively. Among all the synthesized compounds, compounds (4a) and (4j) exhibited the most prominent and consistent anti-inflammatory activity. In acute ulcerogenicity study, it can be concluded that compounds (4a) and (4j) are devoid of the deadlier gastrointestinal toxicities.
Similar content being viewed by others
References
Almasirad A, Tajik M, Bakhtiari D, Shafiee A, Abdollahi M, Zamani MJ, Khorasani R, Esmaily H (2005) Synthesis and analgesic activity of N-arylhydrazone derivatives of mefenamic acid. J Pharm Pharm Sci 8:419–425
Bano S, Javed K, Ahmad S, Rathish IG, Singh S, Chaitanya M, Alam MS (2013) Synthesis of some novel chalcones, flavanones and flavones and evaluation of their anti-inflammatory activity. Eur J Med Chem 65:51–59
Bonifait L, Zhao L, Azelmat J, Genovese S, Epifano F, Grenier D (2014) Synthesis and biological activities of 2, 6-dihydroxy-4-isopentenyloxychalcone as an antimicrobial and anti-inflammatory compound. Med Chem 10(3):300–303
Chandrasekhar T, Kumar LV, Reddy AB, Naik JP, Swamy NG (2012) Synthesis and biological evaluation of some new aryl acid N′-(1Hindazole-3-carbonyl)-hydrazide derivatives. J Chem Phar Res 4:2795–2802
Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926–13931
Cioli V, Putzolu S, Rossi V, Corradino C (1979) The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol Appl Pharmacol 50:283–289
Crofford LJ (1997) COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 49:15–19
Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717
Gokçe M, Utku S, Kupeli E (2009) Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal) hydrazone derivatives. Eur J Med Chem 44:3760–3764
Kam PCA, So A (2009) COX-3: uncertainties and controversies. Current Anaesth Crit Care 20:50–53
Khan MSY, Akhter M (2005) Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid. Die Pharmazie Int J Pharm Sci 60(2):110–114
Kim YH, Kim J, Park H, Kim HP (2007) Anti-inflammatory activity of the synthetic chalcone derivatives: inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharide-treated RAW 264.7 cells. Biol Pharm Bull 30:1450–1455
Mitchell J, Warner T (1999) Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 128:1121–1132
O’Banion MK, Sadowski HB, Winn V, Young DA (1991) A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266:23261–23267
Savić JS, Dilber SP, Marković BD, Milenković MT, Vladimirov SM, Juranić IO (2011) Docking studies and α-substitution effects on the anti-inflammatory activity of β-hydroxy-β-arylpropanoic acids. Molecules 16:6645–6655
Sharma CS, Nema RK, Sharma VK (2009) Synthesis and screening for analgesic and anti-inflammatory activities of some novel amino acid-containing bicyclo compounds. J Young Pharm 1:170–174
Singh HP, Chauhan CS, Pandeya SN, Sharma CS, Srivastava B, Singhal M (2010) Design, synthesis, analgesic and anti-inflammatory activity of some novel chalconesemicarbazone derivatives. Der Pharmacia Lettre 2:460–472
Somani RR, Bhanushali UV (2011) Synthesis and evaluation of antiinflammatory, analgesic and ulcerogenic potential of NSAIDs bearing 1, 3, 4-oxadiazole scaffold. Indian J Pharm Sci 73(6):634–640
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235
Vane JR (2000) The fight against rheumatism: from willow bark to COX-1 Sparing drugs. J Physiol Pharmacol 51:573–586
Willoughby DA, Moore AR, Colville-Nash PR (2000) COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 355:646–648
Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G (2002) Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 19:1446–1457
Acknowledgments
The authors deeply appreciate the assistance of the Department of Pharmacology, B N College of Pharmacy, Udaipur, India, in the biological screening of the compounds. The authors also deeply appreciate the Punjab University, Punjab, India, for providing the spectral studies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, N., Chauhan, L.S., Sharma, C.S. et al. Synthesis, analgesic and anti-inflammatory activities of chalconyl-incorporated hydrazone derivatives of mefenamic acid. Med Chem Res 24, 2580–2590 (2015). https://doi.org/10.1007/s00044-015-1318-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1318-8